The invention relates to a method and a device for producing an implant, wherein a natural bone microstructure of a natural bone region is detected (S1), an implant region in the natural bone region is marked (S2), the detected bone microstructure in the marked implant region is analysed to determine reproduction parameters (S3), and on the basis of the determined reproduction parameters, an artificial microstructure for producing the implant is created (S4).

An orthopedic implant having a metal surface and a calcium phosphate layer disposed on at least part of the metal surface is described. The calcium phosphate layer has an average crystallite size of less than about 100 nm in at least one direction and dissolves for more than 2 hours in vitro. The calcium phosphate layer is substantially free of carbonate. The coating, which is formed on a sodium titanate surface, has increased shear strength and tensile strength. The coating is formed by a solution deposited hydroxyapatite process under inert conditions. The pH of the solution varies by less than 0.1 pH unit/hour during coating formation.

The invention relates to a joint implant for new tissue formation at a joint, wherein the joint implant (1) comprises a rod-shaped body with a base area (11), a cover area (12) and a sleeve area (13), wherein at least the cover area (12), in particular the entire rod-shaped body, of the joint implant (1) has a hydrophobic surface for facilitating chondrocyte differentiation of mesenchymal stem cells, and a thread structure (15) is at least partially formed on the sleeve area (13) of the joint implant (1).

Transcutaneous intraosseous devices with enhanced antimicrobial properties, as well as their production processes are described. Particularly, the transcutaneous intraosseous device comprises an intraosseous part and a transcutaneous part, wherein at least a surface of said transcutaneous part is provided with at least one adhesion or proliferation agent and at least one antimicrobial agent. For instance, the transcutaneous intraosseous device is intraosseous transcutaneous amputation prosthesis.

A medical device comprising a substantially flexible porous structure. The porous structure comprises a plurality of interlocking units. Each of the plurality of interlocking units comprises a body and at least one arm. The plurality of interlocking units is configured to have space between adjacent interlocking units when the porous structure is in a neutral configuration. The plurality of interlocking units is configured to contact the respective body and arm of adjacent interlocking units when a compressive force is applied to the porous structure, thereby restricting compression of the porous structure. The plurality of interlocking units is configured to contact the respective arms of adjacent interlocking units when an extension force is applied to the porous structure, thereby restricting extension of the porous structure.

An implantable permanent filter assembly (1) for deployment in a bifurcated vessel includes a main vessel and at least two branches. This assembly includes a filtering sleeve (2) formed of an expendable braided framework (20) able to expand from a radially compressed state in a delivery configuration to a radially expanded state. The filtering sleeve extends along an axis and defines a cylindrical lumen devoid of impermeable layer, having a distal end configured to extend toward the branches of the bifurcated vessel and a proximal end configured to extend toward away from the branches of the bifurcated vessel. The braided framework has a plurality of mesh layers (22,23,24) of wires (25) made of biocompatible material, forming a lattice with a plurality of wires of each layers. The lattice, when observed normal with respect to a wall of the implantable endoluminal prosthesis, defines polygonal openings.

Disclosed is an implanted device, comprising a device base body and an active drug, wherein the device base body is pure zinc and/or a zinc alloy, the zinc content in the device base body is 0.1-100%, and the active drug comprises anti-allergic drugs. After the implantation of the implanted device into the human body, the surrounding tissues of the implant would not have a clear hypersensitive reaction due to the presence of the anti-allergic drugs, and the implanted device can be used to be implanted into the body for supporting organ chambers, to fill the hollow chambers of the organs and tissues or as orthopaedic implants etc.

An orthopedic implant having a metal surface and a hydroxyapatite layer comprising gallium ions therein disposed on at least part of the metal surface is described. The hydroxyapatite layer has an average crystallite size of less than about 75 nm in at least one direction and dissolves for more than 2 hours in vitro. The hydroxyapatite layer is substantially free of carbonate. The coating, which is formed on a sodium titanate surface, has increased shear strength and tensile strength. The coating is formed by a solution deposited hydroxyapatite process under inert conditions. The pH of the solution varies by less than 0.1 pH unit/hour during coating formation.

A method of implanting a medical implant comprises the steps of reaming a tapered bore to a first depth and a counter bore, coaxial to the tapered bore, to a second depth less than the first depth in a long bone. The counter bore has a larger diameter than the tapered bore. The method further includes inserting a medical implant into the tapered bore and counter bore. The medical implant includes a stem and a collar disposed around a portion of the stem. Inserting the medical implant include fully seating a portion of the stem into the tapered bore to form a press-fit between the stem and the long bone. The collar may be moved into the counter bore to a depth less than the second depth.

A composition and medical implant made therefrom, the composition including a thick diffusion hardened zone, and preferably further including a ceramic layer. Also provided are orthopedic implants made from the composition, methods of making the composition, and methods of making orthopedic implants from the composition.